secwatch.observer — SEC 8-K summary
======================================

Issuer:     STAAR SURGICAL CO (STAA)
CIK:        0000718937
Form:       8-K
Filed at:   2024-10-30T23:59:59+00:00
Accession:  0000950170-24-118953
Event type: earnings
Sentiment:  neutral
Materiality: 0.65
Item codes: 2.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

STAAR Surgical Q3 net sales up 10% to $88.6M; FY China growth outlook halved to 2%
--------------------------------------------------------------------------------

- Net sales $88.6M (+10% YoY); net income $10.0M ($0.20 EPS) vs $4.8M ($0.10) prior year.
- Gross margin 77.3% vs 79.2% due to lower production absorption; operating income $5.7M (6.4% of sales).
- Adjusted EBITDA $16.2M ($0.33) vs $16.5M ($0.33); maintained FY net sales outlook $340-345M.
- China growth outlook cut to ~2% from 10%; APAC 4% (prior 7%), Americas raised to 17% (15%).
- Cash $236.0M; management calls China softness transitory, cites potential policy stimulus.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/718937/000095017024118953/0000950170-24-118953-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/718937/000095017024118953/staa-20241030.htm
  HTML page:      https://secwatch.observer/filing/0000950170-24-118953

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer